I am dedicated to investigating topics of energy homeostasis with a focus on human health and disease biology from a pharmacological perspective. My group employs a combination of state-of-the-art molecular technologies and pharmacological screening to study the role of signaling pathways on energy homeostasis to reveal druggable molecular targets and potential drugs that target them, which have fundamental implications for achieving metabolic health and combating metabolic diseases such as obesity, diabetes, and cardiovascular diseases.